Cresco Labs Inc. (CRLBF) Financials

CRLBF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.3 billion 1000.0 million
March 31, 2026 1.2 billion 957.8 million
Dec. 31, 2025 1.2 billion 943.1 million
Sept. 30, 2025 1.3 billion 940.2 million

CRLBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 5.9 million 3.8 million
March 31, 2026 -13.1 million 5.3 million
Dec. 31, 2025 18.7 million 3.7 million
Sept. 30, 2025 -1.4 million 2.3 million

CRLBF Net Income

No data available :(

CRLBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 32.9 million 419.6 million 164.8 million
March 31, 2026 63.8 million 419.6 million 161.7 million
Dec. 31, 2025 90.9 million 416.3 million 159.3 million
Sept. 30, 2025 45.4 million 326.7 million 247.4 million

CRLBF Shares Outstanding

No data available :(

CRLBF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 9.0 million - 73.6 million -
March 31, 2026 7.5 million - 54.9 million -
Dec. 31, 2025 9.2 million - 61.4 million -
Sept. 30, 2025 7.6 million - 59.2 million -

CRLBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 173.3 million 86.4 million
March 31, 2026 149.2 million 79.7 million
Dec. 31, 2025 164.0 million 84.5 million
Sept. 30, 2025 164.9 million 85.6 million

CRLBF

Price: $0.65

52 week price:
0.59
2.30

Earnings Per Share: -0.15 USD

P/E Ratio: -6.20

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 276.3 million

Links: